Eli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the...

July 2 - The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly's LLY.N donanemab for patients with early Alzheimer's,...

Peter Obi, has recommended that capital punishment be handed out to drug traffickers, as a way of stemming the tide of the menace in Nigeria. Obi made...

On July 3, the Prime Minister made the following statement to Parliament on the Strategic Services Agency (SSA): Madam Speaker, I am authorised by...

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the...

PTC Therapeutics (PTCT) falls as the EC's advisory committee adopts a negative opinion regarding the renewal of the conditional marketing approval of...

The stock market is salivating over the money-making potential in the weight-loss wonder drug. Are we back in the ’70s?

The stock market is salivating over the money-making potential in the weight-loss wonder drug. Are we back in the ’70s?

The hype is enormous: A new weight-loss drug is being aggressively marketed on social media – promising patients a quick fix for obesity. But...

WEDNESDAY, July 3, 2024 -- Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study...